PEDIAVEN AP-HP NOUVEAU-NE 2, solution pour perfusion

solution et solution pour perfusion · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution et solution pour perfusion

Routeintraveineuse

Ingredient entries35

CountryFrance

Product identity

At a glance

Authorisation holder: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - AP-HP
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 63163224

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for PEDIAVEN AP-HP NOUVEAU-NE 2, solution pour perfusion
Ingredient	Strength / reference	Source role
ACIDE ASPARTIQUEcompartiment acides aminés	0,27 g125 ml	SAGroup 3
ALANINEcompartiment acides aminés	0,41 g125 ml	SAGroup 1
HYDROXYDE DE POTASSIUMcompartiment acides aminés	0,11 g125 ml	SAGroup 35
CYSTÉINEcompartiment acides aminés	0,07 g125 ml	FTGroup 4
HISTIDINEcompartiment acides aminés	0,14 g125 ml	SAGroup 8
ISOLEUCINEcompartiment acides aminés	0,2 g125 ml	SAGroup 9
LEUCINEcompartiment acides aminés	0,46 g125 ml	SAGroup 10
LYSINEcompartiment acides aminés	0,36 g125 ml	FTGroup 11
PHÉNYLALANINEcompartiment acides aminés	0,18 g125 ml	SAGroup 13
SÉRINEcompartiment acides aminés	0,25 g125 ml	SAGroup 15
THRÉONINEcompartiment acides aminés	0,23 g125 ml	SAGroup 17
TRYPTOPHANE Lcompartiment acides aminés	0,09 g125 ml	SAGroup 18
VALINEcompartiment acides aminés	0,23 g125 ml	SAGroup 20
CHLORURE DE SODIUMcompartiment acides aminés	0,29 g125 ml	SAGroup 36
ACÉTYLCYSTÉINEcompartiment acides aminés	0,094 g125 ml	SAGroup 4
GLYCINEcompartiment acides aminés	0,14 g125 ml	SAGroup 7
GLUTAMIQUE (ACIDE)compartiment acides aminés	0,46 g125 ml	SAGroup 6
ARGININEcompartiment acides aminés	0,27 g125 ml	SAGroup 2
TAURINEcompartiment acides aminés	0,02 g125 ml	SAGroup 16
MÉTHIONINEcompartiment acides aminés	0,08 g125 ml	SAGroup 12
PROLINEcompartiment acides aminés	0,36 g125 ml	SAGroup 14
TYROSINEcompartiment acides aminés	0,03 g125 ml	SAGroup 19
LYSINE MONOHYDRATÉEcompartiment acides aminés	0,4 g125 ml	SAGroup 11
PHOSPHATE MONOPOTASSIQUEcompartiment acides aminés	0,31 g125 ml	SAGroup 34
IODURE DE POTASSIUMcompartiment glucose	3,3 µg125 ml	SAGroup 29
GLUCONATE DE CALCIUMcompartiment glucose	0,86 g125 ml	SAGroup 22
SULFATE DE CUIVRE PENTAHYDRATÉcompartiment glucose	0,26 mg125 ml	SAGroup 25
GLUCOSE ANHYDREcompartiment glucose	25 g125 ml	FTGroup 21
FLUORURE DE SODIUMcompartiment glucose	49,7 µg125 ml	SAGroup 26
CHROME (CHLORURE DE) HEXAHYDRATÉcompartiment glucose	3,8 µg125 ml	SAGroup 30
GLUCOSE MONOHYDRATÉcompartiment glucose	27,5 g125 ml	SAGroup 21
LACTATE DE MAGNÉSIUM DIHYDRATÉcompartiment glucose	0,098 g125 ml	SAGroup 23
CHLORURE DE MANGANÈSE TÉTRAHYDRATÉcompartiment glucose	5,4 µg125 ml	SAGroup 28
DIOXYDE DE SÉLÉNIUMcompartiment glucose	7,4 µg125 ml	SAGroup 27
ACÉTATE DE ZINC DIHYDRATÉcompartiment glucose	1,93 mg125 ml	SAGroup 24

Pack references

Presentations (1)

10 poche(s) bicompartimenté(e)(s)/à 2 compartiments copolymère (éthylène/propylène) SEBS : styrène-éthylène-butylène-styrène SIS : styrène-isoprène-styrène suremballée(s)/surpochée(s) de 250 ml

CIP13 3400941780776

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 63163224 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →